Begin 2021 with Houston Methodist Academic Institute Town Hall

Houston Methodist Academic Institute is hosting its first town hall of 2021 on Thursday, January 28. Join H. Dirk Sostman, MD, FACR, Ernest Cockrell, Jr. Presidential Distinguished Chair and Houston Methodist Chief Academic Officer, as he presents, "State of the Academic Institute." Hear updates on COVID-19 and educational strategic planning with special guests Timothy Boone, MD, PhD, Trevor Burt, MS, EdD, and Shannan Hamlin, PhD, RN, ACNP-BC, AGACNP-BC, CCRN. All Houston Methodist employees, as well as the public, are invited to attend this virtual event, held 2:00 - 3:30 p.m. It will be livestreamed at watch.houstonmethodist.org/town-hall-January-2021
To submit questions and comments in advance of Town Hall, use this link.
To submit questions and comments in advance of Town Hall, use this link.
Announcements

Gov. Abbott Visits Houston Methodist
On Tuesday, Jan. 19, Gov. Greg Abbott visited Houston Methodist, where he hosted a news conference on a variety of COVID-19 issues. Gov. Abbott shared how impressed he is with Houston Methodist’s efforts, including that we are currently the largest COVID-19 vaccinator in Texas. Houston Methodist was chosen for this visit because of its exceptional work throughout the pandemic. Thanks to our commitment to keeping the patient at the center, Houston Methodist has collectively improved outcomes for COVID-19 patients while reducing hospitalizations overall. In addition to being the first hospital in the country to use convalescent plasma, Houston Methodist also has conducted numerous clinical trials for newly developed treatments. Recent accomplishments include administering such a high volume of monoclonal antibody treatments that we now order directly from the distributor. And being so proficient at administering COVID-19 vaccines, Houston Methodist was chosen as one of the original 28 state hubs to help vaccinate the public.
Leading in Administering Vaccine
Houston Methodist has administered the COVID-19 vaccine to over 56,000 as of Jan. 18. Among its many successes, Houston Methodist held a mega-event on Saturday, Jan. 16, to vaccinate more than 4,000 members of the Houston community from the hardest hit and underserved neighborhoods. Please note that Houston Methodist patients aged 75 or older also have an opportunity to receive the vaccine, as do Category 1B individuals who are over 65 with a chronic medical condition that puts them at increased risk for severe illness from COVID-19. To learn more, email CovidVaccineQuestion@houstonmethodist.org.


Skills Development Workshops for Faculty Career Development
The faculty development team is offering a new series of Skills Development & Communications Workshops for faculty. Led by Dorothy Lewis, PhD, faculty development program director, each 90-minute workshop will be offered biannually, on Tuesdays. The format typically includes an online lecture combined with larger discussion opportunities and small working groups, with registration limited to encourage participation. Find details and registration at the links below:
Presenting at Grand Rounds Workshop - Feb. 2
Creating Research Posters Workshop - Feb. 9
New Microsoft Edge Browser
To enhance security and improve your online experience, Houston Methodist IT has begun deploying the new Microsoft Edge browser, which will continue rolling out over the next two weeks. Compared to other browsers, Microsoft Edge offers faster browsing, enhanced security and identity protection, and easier access to open tabs and web searches. Microsoft Edge will install automatically and appear on your computer and eventually will replace Internet Explorer as the default browser. When Edge is installed, try using it right away to become familiar with it.


NIH Applicants and Funding Recipients Website
The National Institutes of Health Office of Extramural Research continues to offer resources and information for NIH applicants and recipients of NIH Funding. Here are highlights for Jan. 2021:
- New eRA Commons screens were unveiled on Jan. 12. Find insights for using the new eRA Commons home screen (log-in screen) and landing screen (screen when first logged in).
- eRA will require the use of login.gov to access in 2021. Users will be required to use two-factor authentication through login.gov to access eRA Commons, ASSIST, Internet Assisted Review (IAR), and Commons Mobile by September 15, 2021.
- “Human Subjects’ Research Post-Award” is the newest installment of the NIH’s All About Grants podcast series, presented by Lyndi Lahl, RN, NIH Human Subjects’ Officer.
To have NIH notices sent directly to you when they are announced, subscribe to the NIH Extramural Nexus News.

COVID-19 Resources
Houston Methodist provides a variety of tools to facilitate collaborative research projects related to coronavirus. The following resources are available at www.tmh.tmc.edu/tmhri/acma.html
- Elsevier Coronavirus Research Hub
- Curated COVID-19 Funding Opportunities
- National Institutes of Health Coronavirus (COVID-19) Resources
- PURE Coronavirus Portal for Research Collaboration
Accolades

Timothy Bolton Boone, MD, PhD, Craig C. Brown and Suzanne H. Smith Centennial Chair in Medical Education, chair and professor, Department of Urology, director, Regenerative Medicine Program, and chief education officer, Houston Methodist, will be awarded the prestigious Medal of Honor by the Southwestern University Alumni Association at the Distinguished Alumni Awards Presentation on Friday, February 4, 2021. The award is presented to alumni whose accomplishments are regarded as the highest form of achievement.
John Cooke, MD, PhD, Joseph C. “Rusty” Walter and Carole Walter Looke Presidential Distinguished Chair in Cardiovascular Disease Research, chair and professor, Department of Cardiovascular Sciences, and director, Center for Cardiovascular Regeneration, was named a 2020 Mayo Clinic Distinguished Alumni Awardee. The press release states, "Dr. Cooke is an international leader in vascular medicine and biology." Read more here.
Laura Ashley Verzwyvelt, RN III, Cancer Center Infusion, was awarded The Brown Foundation Inc. Outstanding Nurse Award for 2020, which comes with a $15,000 prize. At Houston Methodist Hospital since 2010, Verzwyvelt has participated as a co-investigator on two research pilot studies, with one study most recently receiving a grant from the Center for Health and Nature to pursue additional research into the benefits of nature for oncology patients.
In the Media
Marc Boom, MD, FACHE, president and CEO and Ella Fondren and Josie Roberts Presidential Distinguished Centennial Chair, was quoted from a Jan. 7 email about the $500 Hope Bonus, contingent upon getting the vaccine and other criteria, by news outlets across the country, including CNN.com, Medscape, WebMD and several others, for an audience reach of more than 132 million.
Boom also was interviewed for a Jan. 12 NPR-affiliate story about Houston Methodist's efforts to encourage vaccination, entitled "Houston Methodist Administers 50,000 Vaccinations as City Struggles with Rising COVID-19 Cases."
James M. Musser, MD, PhD, Fondren Presidential Distinguished Chair, chair and professor, Department of Pathology & Genomic Medicine, and director, Center for Molecular & Translational Human Infectious Diseases Research, was interviewed on Jan. 7 about the arrival in Texas of the B117 mutation of COVID-19, speaking with Austin and Houston’s local ABC news affiliates, KVUE-TV and KTRK-TV, Austin’s local NBC affiliate, and KXAN-TV, and the Houston Chronicle.
Deepa Bangalore Gotur, MD, PhD, associate professor of clinical medicine, Department of Medicine, was interviewed for a Jan. 14 Medscape article on her recent study that showed two monoclonal antibodies used to treat rheumatoid arthritis could improve severe COVID-19 outcomes. The article also ran in MDEdge | Infectious Disease, a sister publication to WebMD’s Medscape, and in The Hospitalist, reaching an additional 1.9 million unique visitors through these two publications, in addition to Medscape's audience of 12.7 million. The article referenced a study on tocilizumab conducted by Gotur and her colleagues.
New Employees
We welcome these new employees who joined the Academic Institute on Jan. 11, 2021.
- Solmaz Afshar, Clinical Research Nurse, Medicine - Pulmonary
- Angela Little, Student Professional Nurse, Education - CNREP
- Thomas Nguyen, Research Technician II, Cancer
- Shani Saunders, Research Technician III, Nanomedicine Research
- Chunying Yang, Research Associate III, CV Regeneration
View postings for new job opportunities at the Academic Institute here.
Clinical Research Virtual Career Event
Houston Methodist Academic Institute is sponsoring an online hiring event, to be held Tuesday, Jan. 26, 8:30 – 10:30 a.m. The Clinical Research Virtual Career Event will focus on connecting with clinical research nurses, research coordinators and medical assistants in the Texas Medical Center. You are welcome to share the link with possible candidates: https://events.indeed.com/event/79401/
Publications
The publications with the highest impact factors posted in Scholars, Dec. 22, 2020 - Jan. 12, 2021, include:
Aortic Stenosis and Diastolic Dysfunction: Partners in Crime.
Klein, AL, Ramchand J & Nagueh SF, Journal of the American College of Cardiology.
DOI: 10.1016/j.jacc.2020.10.034
Convalescent Plasma Anti–SARS-CoV-2 Spike Protein Ectodomain and Receptor-binding Domain IgG Correlate with Virus Neutralization
Salazar E, Kuchipudi SV, Christensen PA, Eagar T, Yi X, Zhao P, Jin Z, Long SW, Olsen RJ, Chen J, Castillo B, Leveque C, Towers D, Lavinder J, Gollihar J, Cardona J, Ippolito G, Nissly R, Bird I, Greenawalt D, Rossi RM, Gontu A, Srinivasan S, Poojary I, Cattadori IM, Hudson PJ, Josleyn NM, Prugar L, Huie K, Herbert A, Bernard DW, Dye JM, Kapur V, & Musser JM, Journal of Clinical Investigation, 130(12), 6728-6738.
DOI: 10.1172/JCI141206
Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week
Cainzos Achirica M, Glassner K, Zawahir HS, Dey AK, Agrawal T, Quigley EMM, Abraham BP, Acquah I, Yahya T, Mehta NN & Nasir K, Journal of the American College of Cardiology, 76(24), 2895-2905.
DOI: 10.1016/j.jacc.2020.10.027
Tumor Derived UBR5 Promotes Ovarian Cancer Growth and Metastasis through Inducing Immunosuppressive Macrophages
Song M, Yeku OO, Rafiq S, Purdon T, Dong X, Zhu L, Zhang T, Wang H, Yu Z, Mai J, Shen H, Nixon B, Li M, Brentjens RJ, & Ma X, Nature Communications, 11(1), [6298].
DOI: 10.1038/s41467-020-20140-0
Women who Experience a Myocardial Infarction at a Young Age Have Worse Outcomes Compared with Men: The Mass General Brigham YOUNG-MI Registry
DeFilippi EM, Collins BL, Singh A, Biery DW, Fatima A, Qamar A, Berman AN, Gupta A, Cawley M, Wood MJ, Klein J, Hainer J, Gulati M, Taqueti VR, Di Carli MF, Nasir K, Bhatt DL & Blankstein R, European Heart Journal, 41(42), 4127-4137.
DOI: 10.1093/eurheartj/ehaa662
If you have a featured publication, for example on a journal cover, please let us know so we can include it in our next issue.
Funding Opportunities
DoD Broad Agency Announcement for Extramural Medical Research
The Department of Defense funding for extramural medical research aims to provide solutions to medical problems of importance to the American service members at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology, operational requirements, military threat assessments, and national defense strategies. This funding opportunity is continuously open for a five-year period, from Oct.1, 2017 through Sept. 30, 2022, 11:59 p.m. ET. Access the announcement, including all details, in this PDF. Find the DoD proposal form template in this document.
CITO-PSOC Funding Opportunities
The Center for Immunotherapeutic Transport Oncophysics (CITO) is funded by the NIH to examine the physics of cancer and strategies to improve immunotherapies. Details for the following RFAs are available on the CITO website:
- Trans-Network Projects are small research projects aimed at addressing a challenge in cancer biology from a physical sciences perspective and leveraging the expertise and investigators from multiple PS-OP U01s and/or PS-OC U54s. Focus area(s) and collaborative teams for Trans-Network projects may be proposed by the teams of investigators, with appropriate rationale and justification. The budget is up to $100,000 direct costs per year, with applications submitted on a rolling basis.
- Scientist Exchange Research Program allows scientists (faculty or researchers beyond the trainee level) to conduct laboratory or clinical research with a host investigator within the CITO, PS-ON, or beyond. A main goal of the Scientist Exchange Program is to encourage cross-disciplinary collaborations between research groups. Applications may address any particular challenge and are highly encouraged to complement or synergize with the current CITO projects. The budget is approximately $10,000 in direct costs for up to six months, with applications submitted on a rolling basis.
- Trainee Research allows trainees (postdoctoral, graduate, or undergraduate trainees) to participate in short-term, interactive laboratory or clinical research with a host investigator within the CITO/PS-ON. The proposed research should be under the overarching theme of transport oncophysics, in the context of cancer immunology and immunotherapy. Applications may address any particular challenge and are highly encouraged to complement or synergize with the current CITO projects. The budget is approximately $5,000 in direct costs for up to 10 weeks, with applications submitted on a rolling basis.
All applications should be in PDF and emailed to cito-psoc@houstonmethodist.org. The PS-ON Catalogue of Techniques is available on the Synapse Knowledge Portal, offering additional methods for potential collaboration or training opportunities.
Browse previous issues
Contact us at news@houstonmethodist.org
Houston Methodist Academic Institute
6670 Bertner Avenue, Houston, TX 77030
Copyright © 2021 Houston Methodist Academic Institute, All rights reserved.